We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
1301
Vistance Networks Inc
VISN
$2.66B
$197K 0.01%
160,087
+43,293
+37% +$51.5K
ETRN
1302
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$196K 0.01%
15,137
+3,015
+25% +$40.4K
CRK icon
1303
Comstock Resources
CRK
$3.97B
$196K 0.01%
18,860
+3,585
+23% +$37.6K
SDGR icon
1304
Schrodinger
SDGR
$1.12B
$194K 0.01%
10,031
+1,264
+14% +$29.1K
BILI icon
1305
Bilibili
BILI
$7.18B
$190K 0.01%
12,275
-1,095
-8% -$15.3K
OPRA
1306
Opera Ltd
OPRA
$1.65B
$189K 0.01%
13,482
+1,659
+14% +$23.6K
AVDX
1307
DELISTED
AvidXchange
AVDX
$185K 0.01%
15,330
-1,386
-8% -$15.8K
CUK
1308
DELISTED
Carnival PLC
CUK
$184K 0.01%
10,671
-5,543
-34% -$77.6K
AQN icon
1309
Algonquin Power & Utilities
AQN
$4.69B
$180K 0.01%
30,699
+2,750
+10% +$17K
PARA
1310
DELISTED
Paramount Global Class B
PARA
$180K 0.01%
17,297
+3,015
+21% +$35.3K
SAGE
1311
DELISTED
Sage Therapeutics
SAGE
$179K 0.01%
+16,528
New +$212K
AES icon
1312
AES
AES
$10.6B
$178K ﹤0.01%
10,158
-1,448
-12% -$27.5K
ADPT icon
1313
Adaptive Biotechnologies
ADPT
$3.56B
$174K ﹤0.01%
48,016
+12,529
+35% +$39.8K
LESL icon
1314
Leslie's
LESL
$11.6M
$171K ﹤0.01%
+2,035
New +$198K
UNIT
1315
Uniti Group
UNIT
$2.63B
$166K ﹤0.01%
56,939
+22,811
+67% +$95.6K
BRFS
1316
DELISTED
BRF SA
BRFS
$164K ﹤0.01%
40,306
+3,645
+10% +$12.8K
PLUG icon
1317
Plug Power
PLUG
$2.92B
$158K ﹤0.01%
67,882
+935
+1% +$2.68K
SANA icon
1318
Sana Biotechnology
SANA
$885M
$158K ﹤0.01%
28,939
+1,880
+7% +$15K
VIR icon
1319
Vir Biotechnology
VIR
$1.47B
$155K ﹤0.01%
17,419
+5,391
+45% +$51.7K
STNE icon
1320
StoneCo
STNE
$2.62B
$155K ﹤0.01%
+12,919
New +$191K
ALEC icon
1321
Alector
ALEC
$164M
$154K ﹤0.01%
33,978
+11,967
+54% +$61.6K
TIGR
1322
UP Fintech Holding
TIGR
$845M
$153K ﹤0.01%
36,501
-1,507
-4% -$5.95K
AGNC icon
1323
AGNC Investment
AGNC
$12.3B
$153K ﹤0.01%
+16,015
New +$153K
RGNX icon
1324
Regenxbio
RGNX
$623M
$151K ﹤0.01%
12,918
+3,386
+36% +$52.7K
BYND icon
1325
Beyond Meat
BYND
$288M
$150K ﹤0.01%
22,427
+734
+3% +$5.21K

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.